Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.23.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities    
Net (loss) income $ (19,797) $ 2,726
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Stock-based compensation 1,792 1,650
Depreciation 1,690 1,460
Amortization of intangible assets 4,651 4,705
Deferred income taxes (124) (905)
Amortization of inventory fair value adjustments 0 (1,599)
Amortization of debt issuance costs and original issue discount 522 456
Change in fair value of warrant liabilities (154) (861)
Changes in current assets and liabilities:    
Accounts receivable 706 (3,821)
Inventories 1,579 (878)
Prepaid expenses and other current assets (740) (842)
Accounts payable, accrued liabilities and income taxes 14,084 4,833
Other, net (142) (2,478)
Net cash provided by operating activities 4,067 4,446
Investing activities    
Capital expenditures (1,556) (3,276)
Proceeds from the sale of fixed assets 0 50
Net cash used in investing activities (1,556) (3,226)
Financing activities    
Proceeds from revolving credit facility 0 30,000
Repayments of revolving credit facility (4,000) 0
Repayments of long-term borrowings (938) (938)
Payment of contingent consideration 0 (29,108)
Tax withholdings related to net share settlements of stock awards (405) (291)
Net cash used in financing activities (5,343) (337)
Effect of exchange rate changes on cash and cash equivalents 788 186
Net change in cash and cash equivalents (2,044) 1,069
Cash and cash equivalents, beginning of period 28,676 28,296
Cash and cash equivalents, end of period 26,632 29,365
Supplemental disclosure of cash flow information    
Interest paid 10,284 5,567
Taxes paid, net of refunds $ 3,228 $ 993